Patents-Review.com
ClassID:

20525 ⎘

A61K31/7056 - page 4 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom

Recent Application in this class:
#901
20130115190
2013-05-09

Hepatitis C virus inhibitors

 #902
20130109648
2013-05-02

Method for treating a human patent suffering from Myeloid Neoplasias using 5-aminoimidazole-4-carboxamide

 #903
20130109647
2013-05-02

METHODS AND COMPOSITIONS FOR TREATING HEPATITIS C VIRUS

 #904
20130109617
2013-05-02

Substituted tetracycline compounds for treatment of infections

 #905
20130102557
2013-04-25

Methods for treating HCV

 #906
20130102525
2013-04-25

Methods for treating HCV

 #907
20130101653
2013-04-25

Methods and materials for reducing the risk of infections

 #908
20130101554
2013-04-25

Therapeutic regimen comprising PEG-interferon, ribavirin and VX-950 for the treatment of hepatitis

 #909
20130096076
2013-04-18

PHARMACEUTICAL COMPOSITION COMPRISING A SGLT2 INHIBITOR IN COMBINATION WITH A DPP-IV INHIBITOR

 #910
20130095068
2013-04-18

AGENT FOR TREATING HCV INFECTION

 #911
20130093517
2013-04-18

Buffer amplifier

 #912
20130090305
2013-04-11

METHOD USING A DIETARY SUPPLEMENT FOR HEALING OR REGRESSING SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE, GASTRITIS AND ULCERS

 #913
20130089623
2013-04-11

Methods and compositions for treating thyroid-related medical conditions with reduced folates

 #914
20130078218
2013-03-28

HEPATITIS C THERAPIES

 #915
20130072673
2013-03-21

Chirally correct retinal cyclodextrin hemiacetals for clarifying skin complexion

 #916
20130072528
2013-03-21

Methods for Treating HCV

 #917
20130071354
2013-03-21

Modulators of toll-like receptors

 #918
20130071352
2013-03-21

5,5-fused arylene or heteroarylene hepatitis C virus inhibitors

 #919
20130058904
2013-03-07

Composition for modulating inflammation of cardiovascular tissue

 #920
20130045932
2013-02-21

RETINOID TOPICAL COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONS

 #921
20130045269
2013-02-21

FORMULATIONS AND METHODS FOR WOUND TREATMENT

 #922
20130045240
2013-02-21

COMBINATION THERAPY WITH NANOPARTICLE COMPOSITIONS OF TAXANE AND HEDGEHOG INHIBITORS

 #923
20130034522
2013-02-07

THERAPIES FOR TREATING HEPATITIS C VIRUS INFECTION

 #924
20130022609
2013-01-24

Method of treating androgen independent prostate cancer

 #925
20130017171
2013-01-17

METHODS AND COMPOSITIONS FOR TREATING HEPATITIS C VIRUS

 #926
20130012561
2013-01-10

Estrogen receptor modulators and uses thereof

 #927
20130012460
2013-01-10

Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent

 #928
20130011852
2013-01-10

Compounds that interact with kinases

 #929
20130005804
2013-01-03

Novel Uses of Neuraminidase Inhibitors in Infectious Diseases

 #930
20130004457
2013-01-03

Hepatitis C virus inhibitors

 #931
20120309701
2012-12-06

Compounds and methods for treating bacterial infections

 #932
20120309677
2012-12-06

METHODS FOR REGULATING BLOOD GLUCOSE LEVELS

 #933
20120308519
2012-12-06

Anti-arenaviral compounds

 #934
20120288529
2012-11-15

PHARMACEUTICAL EXCIPIENT, METHOD FOR ITS PREPARATION AND USE THEREOF

 #935
20120283308
2012-11-08

Animal feed composition

 #936
20120283210
2012-11-08

Maribavir isomers, compositions, methods of making and methods of using

 #937
20120282224
2012-11-08

MARKERS ASSOCIATED WITH RIBAVIRIN-INDUCED ANEMIA

 #938
20120277177
2012-11-01

Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole

 #939
20120276051
2012-11-01

Inhibitors of hepatitis C virus

 #940
20120270819
2012-10-25

USE OF COMPOUNDS WITH SGLT-1/SGLT-2 INHIBITOR ACTIVITY FOR PRODUCING MEDICAMENTS FOR TREATMENT OF BONE DISEASE

 #941
20120264796
2012-10-18

METHODS FOR MODULATING CIRCADIAN RHYTHMS

 #942
20120264737
2012-10-18

Heterocyclic modulators of lipid synthesis

 #943
20120263625
2012-10-18

Glyco-substituted dihydroxy-chlorins and β-functionalized chlorins for anti-microbial photodynamic therapy

 #944
20120258926
2012-10-11

FORMULATIONS OF ACADESINE

 #945
20120258913
2012-10-11

Glucopyranoside compound

 #946
20120258177
2012-10-11

Microcapsules comprising benzoyl peroxide and topical compositions comprising them

 #947
20120251497
2012-10-04

Inhibitors of hepatitis C virus

 #948
20120245116
2012-09-27

Inhibiting GS-FDH to Modulate No Bioactivity

 #949
20120237480
2012-09-20

2′allene-substituted nucleoside derivatives

 #950
20120220619
2012-08-30

Rapamycin Derivative or an Impdh Inhibitor for Treating Polycystic Kidney Disease

 #951
20120213732
2012-08-23

TARGETED DELIVERY OF ANTIVIRAL COMPOUNDS THROUGH HEMOGLOBIN BIOCONJUGATES

 #952
20120213709
2012-08-23

Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses

 #953
20120207828
2012-08-16

LARGE DOSE RIBAVIRIN FORMULATIONS

 #954
20120202789
2012-08-09

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER

 #955
20120196813
2012-08-02

Glycoside derivative and uses thereof

 #956
20120190640
2012-07-26

Cyanocobalamin low viscosity aqueous formulations for intranasal delivery

 #957
20120190637
2012-07-26

COMBINATION THERAPY TREATMENT FOR VIRAL INFECTIONS

 #958
20120183496
2012-07-19

Inhibitors of hepatitis C virus polymerase

 #959
20120178709
2012-07-12

Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole

 #960
20120178708
2012-07-12

Phenethylsulfone isoindoline derivatives and their use

 #961
20120177601
2012-07-12

TREATMENT OF HEPATITIS C VIRUS INFECTIONS

 #962
20120171157
2012-07-05

Macrocylic inhibitors of hepatitis C virus

 #963
20120164222
2012-06-28

Compounds and compositions and methods of use

 #964
20120157508
2012-06-21

Targeting EN2, PAX2, and/or DEFB1 for treatment of prostate conditions

 #965
20120148534
2012-06-14

Methods and compositions of treating a family viral infection

 #966
20120141414
2012-06-07

Bimacrocylic HCV NS3 protease inhibitors

 #967
20120135949
2012-05-31

COMBINATION THERAPY FOR TREATING HCV INFECTION

 #968
20120134985
2012-05-31

METHODS FOR MODULATING METABOLIC AND CIRCADIAN RHYTHMS

 #969
20120114604
2012-05-10

Combinations for HCV Treatment

 #970
20120114590
2012-05-10

IL28 AND IL29 TRUNCATED CYSTEINE MUTANTS AND ANTIVIRAL METHODS OF USING SAME

 #971
20120108539
2012-05-03

Medicinal Anti Acne Cream And A Process To Make It

 #972
20120108527
2012-05-03

Polymeric topical compositions

 #973
20120107274
2012-05-03

2'-FLUORO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT

 #974
20120100105
2012-04-26

AGENT AND METHOD FOR TREATING REFRACTORY CHRONIC HEPATITIS C

 #975
20120088671
2012-04-12

Anti-biofilm compositions and methods for using

 #976
20120083488
2012-04-05

Tetracyclic compound

 #977
20120076756
2012-03-29

Benzimidazole derivatives

 #978
20120071535
2012-03-22

Estrogen receptor modulators and uses thereof

 #979
20120071349
2012-03-22

Anti-aging agents and methods to identify them

 #980
20120070518
2012-03-22

METHODS AND COMPOSITIONS FOR TREATING PSORIASIS

 #981
20120070415
2012-03-22

Azido nucleosides and nucleotide analogs

 #982
20120064135
2012-03-15

Benzoyl Peroxide Composition, Methods for Making Same, and Pharmaceutical or Cosmetic Formulations Comprising Same, and Uses Thereof

 #983
20120058121
2012-03-08

Methods and compositions for treating lupus

 #984
20120058080
2012-03-08

7-nitro-2-(3-nitro phenyl)-4H-3,1-benzoxazin-4-one or derivatives thereof for treating or preventing antiviral infections

 #985
20120045415
2012-02-23

Treatment of hepatitis C virus with telaprevir (VX-950) in patients non-responsive to treatment with pegylated interferon-alpha 2A/2B and ribavirin

 #986
20120039850
2012-02-16

HCV Combination Therapies Comprising Pegylated Interferon, Ribavirin and Telaprevir

 #987
20120039848
2012-02-16

Hepatitis C virus inhibitors

 #988
20120035130
2012-02-09

Chirally correct retinal cyclodextrin hemiacetals for clarifying skin complexion

 #989
20120022046
2012-01-26

Thienopyridine derivatives for the treatment and prevention of dengue virus infections

 #990
20120022016
2012-01-26

Compounds and methods for selectively targeting tumor-associated mucins

 #991
20120014913
2012-01-19

Process for preparing antiviral compounds

 #992
20120010163
2012-01-12

Antibacterial compounds, methods of making them, and uses thereof

 #993
20120009147
2012-01-12

2'-fluoro substituted carba-nucleoside analogs for antiviral treatment

 #994
20110319352
2011-12-29

Compounds That Bind Oxysterol Binding Proteins, and Methods of Use Thereof

 #995
20110318338
2011-12-29

Targeting PAX2 for the treatment of breast cancer

 #996
20110318278
2011-12-29

Foamable suspension gel

 #997
20110306566
2011-12-15

TOPICAL SKIN TREATMENT KITS

 #998
20110306138
2011-12-15

Complex and method for enhancing nuclear delivery

 #999
20110300104
2011-12-08

Hepatitis C virus inhibitors

 #1000
20110295012
2011-12-01

Macrocyclic inhibitors of hepatitis C virus

 #1001
20110293719
2011-12-01

Compounds and compositions and methods of use

 #1002
20110286969
2011-11-24

DEUTERATED COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS

 #1003
20110286962
2011-11-24

Compounds and pharmaceutical compositions for the treatment of viral infections

 #1004
20110280847
2011-11-17

Methods and compositions for inhibiting clostridium difficile spore germination and outgrowth

 #1005
20110274655
2011-11-10

Tetrazolones as inhibitors of fatty acid synthase

 #1006
20110274652
2011-11-10

Methods for Treating Hepatitis C Virus Infection

 #1007
20110270212
2011-11-03

PHARMACOKINETIC CONTROL FOR OPTIMIZED INTERFERON DELIVERY

 #1008
20110268801
2011-11-03

Compounds and compositions and methods of use

 #1009
20110268700
2011-11-03

Dosage regimens for HCV combination therapy

 #1010
20110268677
2011-11-03

Silicone paste compositions

 #1011
20110263920
2011-10-27

Advanced methods and systems for treating cell proliferation disorders

 #1012
20110251141
2011-10-13

COMPOSITION FOR TOPICAL TREATMENT OF MIXED VAGINAL INFECTIONS

 #1013
20110245200
2011-10-06

USE OF IDRABIOTAPARINUX FOR DECREASING THE INCIDENCE OF BLEEDINGS DURING AN ANTITHROMBOTIC TREATMENT

 #1014
20110245188
2011-10-06

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES OR CONDITIONS

 #1015
20110243937
2011-10-06

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

 #1016
20110243894
2011-10-06

METHODS OF TREATING HEPATITIS C VIRUS INFECTION

 #1017
20110243886
2011-10-06

Compounds and pharmaceutical compositions for the treatment of viral infections

 #1018
20110237662
2011-09-29

Method of treating inflammation with statins

 #1019
20110237534
2011-09-29

Methods for treating gastrointestinal diseases

 #1020
20110236351
2011-09-29

Therapeutic Regimen Comprising PEG-Interferon, Ribavirin and VX-950 for the Treatment of Hepatitis

 #1021
20110236321
2011-09-29

Aerosol foams comprising clindamycin phosphate

 #1022
20110230654
2011-09-22

Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs

 #1023
20110230432
2011-09-22

COMPOSITIONS AND KITS FOR TREATING INFLUENZA

 #1024
20110229585
2011-09-22

Nutrient compositions and methods for enhanced effectiveness of the immune system

 #1025
20110229468
2011-09-22

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

 #1026
20110229467
2011-09-22

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

 #1027
20110229438
2011-09-22

METHOD OF INHIBITING HEPATITUS C VIRUS BY COMBINATION OF A 5,6-DIHYDRO-1H-PYRIDIN-2-ONE AND ONE OR MORE ADDITIONAL ANTIVIRAL COMPOUNDS

 #1028
20110223238
2011-09-15

Bisbenzamidines for the treatment of pneumonia

 #1029
20110223162
2011-09-15

Targeting PAX2 for the treatment of breast cancer

 #1030
20110223161
2011-09-15

Targeting PAX2 for the treatment of breast cancer

 #1031
20110217299
2011-09-08

Targeting PAX2 for the treatment of breast cancer

 #1032
20110212157
2011-09-01

DERMAL DELIVERY

 #1033
20110212089
2011-09-01

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

 #1034
20110212033
2011-09-01

Oil and liquid silicone foamable carriers and formulations

 #1035
20110207690
2011-08-25

Compositions and methods for treating viral infections

 #1036
20110206666
2011-08-25

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

 #1037
20110206665
2011-08-25

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

 #1038
20110201566
2011-08-18

Methods for treating resistant diseases using triazole containing macrolides

 #1039
20110196013
2011-08-11

Animal feed composition

 #1040
20110195920
2011-08-11

Biodefenses using triazole-containing macrolides

 #1041
20110195919
2011-08-11

COMBINATION THERAPY FOR ACNE VULGARIS COMPRISING ADMINISTRATION OF ADAPALENE 0.3% GEL AND CLINDAMYCIN/BENZOYL PEROXIDE GEL

 #1042
20110190233
2011-08-04

Anionic conjugates of glycosylated bacterial metabolite

 #1043
20110190230
2011-08-04

Betalain compositions and uses thereof

 #1044
20110189771
2011-08-04

Imino sugar derivatives demonstrate potent antiviral activity and reduced toxicity

 #1045
20110189175
2011-08-04

Chronic lymphocytic leukemia prognosis and treatment

 #1046
20110183943
2011-07-28

Concurrent therapy regime/regimen for the treatment of acne related diseases

 #1047
20110182858
2011-07-28

SILIBININ COMPONENT FOR THE TREATMENT OF HEPATITIS

 #1048
20110182852
2011-07-28

IL28 AND IL29 TRUNCATED CYSTEINE MUTANTS AND ANTIVIRAL METHODS OF USING SAME

 #1049
20110171174
2011-07-14

Synergistic Combinations of a Macrocyclic Inhibitor of HCV and a Nucleoside

 #1050
20110166087
2011-07-07

PHARMACEUTICAL COMPOSITION FOR USE IN TREATING SEXUALLY TRANSMITTED INFECTIONS

 #1051
20110165119
2011-07-07

TELAPREVIR DOSING REGIMEN

 #1052
20110160157
2011-06-30

Methods of treating an inflammatory-related disease

 #1053
20110152275
2011-06-23

AGENT FOR MAINTENANCE OF INDUCED REMISSION

 #1054
20110152237
2011-06-23

Chemical compounds

 #1055
20110150827
2011-06-23

5,5-fused arylene or heteroarylene hepatitis C virus inhibitors

 #1056
20110144048
2011-06-16

Novel Uses of Neuraminidase Inhibitors in Infectious Diseasess

 #1057
20110144003
2011-06-16

Maintenance therapy regime/regimen for the treatment of acne

 #1058
20110142922
2011-06-16

STABILIZED COMPOSITION AND METHOD FOR DERMATOLOGICAL TREATMENT

 #1059
20110142913
2011-06-16

Composition and method for treating atherosclerosis, method for determining if a subject has atherosclerosis and method of screening an anti-atherosclerotic drug

 #1060
20110136852
2011-06-09

Rapamycin Derivative or an Impdh Inhibitor for Treating Polycystic Kidney Disease

 #1061
20110136754
2011-06-09

Triazole derivatives, their preparation and their application in therapeutics

 #1062
20110135605
2011-06-09

METHODS AND PRODUCTS RELATED TO TREATMENT AND PREVENTION OF HEPATITIS C VIRUS INFECTION

 #1063
20110123516
2011-05-26

Nitrogenated derivatives of pancratistatin

 #1064
20110118334
2011-05-19

Antisense antiviral compound and method for treating influenza viral infection

 #1065
20110118203
2011-05-19

Crystalline forms of an antiviral benzimidazole compound

 #1066
20110117055
2011-05-19

Methods of Treating Hepatitis C Virus with Oxoacetamide Compounds

 #1067
20110117054
2011-05-19

USE OF RIBAVIRIN IN BLOOD COAGULATION DISORDER

 #1068
20110104186
2011-05-05

Small molecule immunopotentiators and assays for their detection

 #1069
20110098240
2011-04-28

PHARMACEUTICAL COMPOSITION COMPRISING A SGLT2 INHIBITOR IN COMBINATION WITH A DPP-IV INHIBITOR

 #1070
20110097753
2011-04-28

Chemiluminescent methods and reagents for analyte detection

 #1071
20110091423
2011-04-21

Compositions and methods of use of ritonavir for treating HCV

 #1072
20110082098
2011-04-07

NOVOBIOCIN ANALOGUES AND TREATMENT OF POLYCYSTIC KIDNEY DISEASE

 #1073
20110064696
2011-03-17

Hepatitis C virus inhibitors

 #1074
20110064694
2011-03-17

ANTI-HEPATITIS C ACTIVITY OF MESO-TETRAKIS-PORPHYRIN ANALOGUES

 #1075
20110059912
2011-03-10

Combination therapy comprising SGLT inhibitors and DPP4 inhibitors

 #1076
20110059886
2011-03-10

HCV NS3-NS4A Protease Inhibition

 #1077
20110059047
2011-03-10

NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION

 #1078
20110052536
2011-03-03

Methods of treating a family viral infection and compositions for treating a family viral infection

 #1079
20110052534
2011-03-03

Imidazopyridazine Compounds for Treating Viral Infections

 #1080
20110045535
2011-02-24

Activator for Blood Coagulation Factor VII Promoter and Utilization of the Same

 #1081
20110045037
2011-02-24

Foam containing benzoyl peroxide

 #1082
20110039797
2011-02-17

Oligomer conjugates of heteropentacyclic nucleosides

 #1083
20110027229
2011-02-03

CONTINUOUS SUBCUTANEOUS ADMINISTRATION OF INTERFERON-ALPHA TO HEPATITIS C INFECTED PATIENTS

 #1084
20110020311
2011-01-27

Therapy of neurological inflammatory diseases with (5'-deoxy-5'-adenosyl) cobamamide, recombinant human growth hormone, interleukins IL-1, IL-6, IL-11, epidermal growth factor, and physiotherapy

 #1085
20110020272
2011-01-27

COMBINATION THERAPY FOR TREATING HEPATITIS VIRAL INFECTION

 #1086
20110020270
2011-01-27

Compositions comprising E-selectin antagonists and uses therefor

 #1087
20110008464
2011-01-13

Methods and compositions for treating thyroid-related medical conditions with reduced folates

 #1088
20110008288
2011-01-13

Hepatitis C virus inhibitors

 #1089
20110008266
2011-01-13

Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses

 #1090
20110002881
2011-01-06

Treatment of immunocompromised conditions

 #1091
20100331275
2010-12-30

Supporting activities of daily living

 #1092
20100331274
2010-12-30

Antiaging chirally-correct mitoprotectant amino acid and peptide complexes

 #1093
20100324110
2010-12-23

Self solidifying bioerodible barrier implant

 #1094
20100323979
2010-12-23

METHODS AND COMPOSITIONS FOR INHIBITING PROLIFERATION OF ANEUPLOID CELLS

 #1095
20100317575
2010-12-16

PHARMACEUTICAL COMPOSITION COMPRISING A PYRAZOLE-O-GLUCOSIDE DERIVATIVE

 #1096
20100316607
2010-12-16

Hepatitis C virus inhibitors

 #1097
20100316594
2010-12-16

MODIFIED 2' AND 3' NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS

 #1098
20100310476
2010-12-09

Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof

 #1099
20100297033
2010-11-25

Megaribavirin alone or combination of other antiviral, antioxidant and a perflubron emulsion for treatment of viral disease

 #1100
20100261666
2010-10-14

COMPOSITIONS AND METHODS FOR THE TREATMENT OF MYOCARDIAL DYSFUNCTION ASSOCIATED WITH SIRS OR SEPSIS

 #1101
20100260733
2010-10-14

Anti aging agents and methods to identify them

 #1102
20100260717
2010-10-14

Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection

 #1103
20100254942
2010-10-07

HEPATITIS C ANTIVIRAL COMPOSITIONS AND METHODS

 #1104
20100234295
2010-09-16

Treating alzheimer's disease and osteoporosis and reducing aging

 #1105
20100226889
2010-09-09

HCV Combination Therapies

 #1106
20100226888
2010-09-09

Ethanol Enhances the Complete Replication of Hepatitis C Virus: the Role of Acetaldehyde

 #1107
20100221325
2010-09-02

DIETARY SUPPLEMENT FOR HEALING OR REGRESSING SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE, GASTRITIS AND ULCERS

 #1108
20100216734
2010-08-26

MODULATION OF NEUROGENESIS BY NOOTROPIC AGENTS

 #1109
20100215616
2010-08-26

Hepatitis C virus inhibitors

 #1110
20100209505
2010-08-19

Controlled release pharmaceutical formulations of nitazoxanide

 #1111
20100209421
2010-08-19

Targeting PAX2 for the treatment of breast cancer

 #1112
20100203127
2010-08-12

LARGE DOSE RIBAVIRIN FORMULATIONS

 #1113
20100203013
2010-08-12

Treating Hepatitis C Virus Infection

 #1114
20100189688
2010-07-29

Dose forms comprising VX-950 and their dosage regimen

 #1115
20100184642
2010-07-22

Transgenic plants expressing cobalamin binding proteins

 #1116
20100179101
2010-07-15

Novel Crystalline Forms Of An Antiviral Benzimidazole Compound

 #1117
20100173855
2010-07-08

Dermatalogical formulations

 #1118
20100168053
2010-07-01

ORAL DELIVERY SYSTEM FOR METHYLCOBALAMIN TO TREAT DISORDERS

 #1119
20100167989
2010-07-01

ISOPROPOXYPHENYLMETHYL INHIBITORS OF SGLT2

 #1120
20100143301
2010-06-10

Modulators of toll-like receptors

 #1121
20100143300
2010-06-10

Hepatitis C therapies

 #1122
20100143296
2010-06-10

PODOPHYLLOTOXIN INHIBITORS OF TOPOISOMERASE II

 #1123
20100143295
2010-06-10

QUINAZOLINE INHIBITORS OF EGFR TYROSINE KINASE

 #1124
20100135956
2010-06-03

STEROID MODULATORS OF PROGESTERONE RECEPTOR AND/OR GLUCOCORTICOID RECEPTOR

 #1125
20100129437
2010-05-27

TARGETED INTRACELLULAR DELIVERY OF ANTIVIRAL AGENTS

 #1126
20100124554
2010-05-20

REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS

 #1127
20100113358
2010-05-06

Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amyloid beta

 #1128
20100111839
2010-05-06

Selective inhibitors of translesion DNA replication

 #1129
20100098702
2010-04-22

METHOD OF TREATING ANDROGEN INDEPENDENT PROSTATE CANCER

 #1130
20100087500
2010-04-08

Methods and compositions for treatment of acute heart failure

 #1131
20100074840
2010-03-25

Anthracycline-Antibody Conjugates for Cancer Therapy

 #1132
20100068284
2010-03-18

Stable fixed dose topical formulation

 #1133
20100068182
2010-03-18

Combination therapy for treating HCV infection

 #1134
20100063124
2010-03-11

NEW PYRAZOLE DERIVATIVES AND DIABETIC MEDICINE CONTAINING THEM

 #1135
20100056445
2010-03-04

ADIPONECTIN FOR THE TREATMENT AND DIAGNOSIS OF ALBUMINURIA

 #1136
20100029919
2010-02-04

Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same

 #1137
20100029765
2010-02-04

TOPICAL AQUEOUS COMPOSITION COMPRISING TRETINOIN

 #1138
20100028922
2010-02-04

IDENTIFICATION AND CHARACTERIZATION OF HCV REPLICON VARIANTS WITH REDUCED SUSCEPTIBILITY TO BENZOFURANS, AND METHODS RELATED THERETO

 #1139
20100021458
2010-01-28

Polycyclic agents for the treatment of respiratory syncytial virus infections

 #1140
20100021429
2010-01-28

Cladribine regimen for treating multiple sclerosis

 #1141
20100021426
2010-01-28

Methods for making and compositions comprising fermentation products of cordyceps sinensis

 #1142
20100015121
2010-01-21

Inhibiting GS-FDH to modulate no bioactivity

 #1143
20100015093
2010-01-21

Methods and compositions of treating a family viral infection

 #1144
20100015090
2010-01-21

Combinations for HCV Treatment

 #1145
20090326037
2009-12-31

Medicinal Agent For Treating Viral Infections

 #1146
20090325895
2009-12-31

Methods of treating an inflammatory-related disease

 #1147
20090318379
2009-12-24

Statins for the Treatment of Viral Influenza Infections

 #1148
20090317453
2009-12-24

TRANSDERMAL AND TOPICAL ADMINISTRATION OF DRUGS USING BASIC PERMEATION ENHANCERS

 #1149
20090306172
2009-12-10

Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent

 #1150
20090298786
2009-12-03

METHODS OF TREATING VIRAL INFECTIONS WITH ANTHRACYCLINE ANTIBIOTICS

 #1151
20090281140
2009-11-12

Macrocyclic inhibitors of hepatitis C virus

 #1152
20090281050
2009-11-12

Anti-bacterial activity of 9-hydroxy derivatives of 6,11-bicyclolides

 #1153
20090280086
2009-11-12

Methods and compositions for treating hepatitis C virus

 #1154
20090269305
2009-10-29

Macrocyclic inhibitors of hepatitis C virus replication

 #1155
20090252708
2009-10-08

Biotherapeutic compositions comprising probiotic escherichia coli and uses thereof

 #1156
20090247481
2009-10-01

Compositions and kits for treating influenza

 #1157
20090239818
2009-09-24

EFFECTIVE TREATMENT OF OVARIAN CANCER USING TRICIRIBINE AND RELATED COMPOUNDS

 #1158
20090238790
2009-09-24

Compounds and Pharmaceutical Compositions for the Treatment of Viral Infections

 #1159
20090232769
2009-09-17

Pharmaceutical composition for treatment of blood clotting disorder

 #1160
20090226400
2009-09-10

CONTINUOUS DELIVERY METHODS FOR TREATING HEPATITIS VIRUS INFECTION

 #1161
20090215869
2009-08-27

Hepatitis C virus non-structural NS3/4A fusion gene

 #1162
20090214596
2009-08-27

Nasal Vaccine

 #1163
20090203633
2009-08-13

Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof

 #1164
20090197849
2009-08-06

TRANSDERMAL AND TOPICAL ADMINISTRATION OF DRUGS USING BASIC PERMEATION ENHANCERS

 #1165
20090197825
2009-08-06

Compounds and compositions and methods of use

 #1166
20090192120
2009-07-30

INHIBITORS OF NITRIC OXIDE SYNTHASE

 #1167
20090176721
2009-07-09

NUCLEOSIDE ANALOGS WITH CARBOXAMIDINE MODIFIED MONOCYCLIC BASE

 #1168
20090169504
2009-07-02

Compounds and pharmaceutical compositions for the treatment of viral infections

 #1169
20090148511
2009-06-11

COMPOSITION AND METHOD FOR DERMATOLOGICAL TREATMENT

 #1170
20090136496
2009-05-28

Chronic lymphocytic leukemia prognosis and treatment

 #1171
20090130059
2009-05-21

Tetrazolyl macrocyclic hepatitis C serine protease inhibitors

 #1172
20090123425
2009-05-14

Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors

 #1173
20090093419
2009-04-09

Glucopyranosyloxypyrazole derivatives and use thereof in medicines

 #1174
20090075916
2009-03-19

Use of Macrolide Derivatives for Treating Acne

 #1175
20090068142
2009-03-12

COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTION AND SARS

 #1176
20090068140
2009-03-12

Hepatitis C virus inhibitors

 #1177
20090054360
2009-02-26

Method and composition for treating allergic diseases

 #1178
20090054356
2009-02-26

1-substituted-7-(β-D-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same

 #1179
20090047248
2009-02-19

Triazolyl macrocyclic hepatitis C serine protease inhibitors

 #1180
20090042823
2009-02-12

USES OF BROAD SPECTRUM RNAI THERAPEUTICS AGAINST INFLUENZA

 #1181
20090042822
2009-02-12

Method to enhance delivery of glutathione and ATP levels in cells

 #1182
20090035271
2009-02-05

TETRAZOLYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS

 #1183
20090028820
2009-01-29

Antiviral Agent

 #1184
20090022788
2009-01-22

DIETARY SUPPLEMENT FOR HEALING OR REGRESSING SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE, GASTRITIS AND ULCERS

 #1185
20090017108
2009-01-15

Liposome compositions for treatment of hepatitis C

 #1186
20090012015
2009-01-08

LARGE DOSE RIBAVRIN FORMULATONS

 #1187
20080318207
2008-12-25

Sequence covariance networks, methods and uses therefor

 #1188
20080317714
2008-12-25

Method of Treating Hepatitis B Viral Infection

 #1189
20080312245
2008-12-18

Methods and compositions for treating acne and other infectious diseases

 #1190
20080286230
2008-11-20

Compounds and pharmaceutical compositions for the treatment of viral infections

 #1191
20080280940
2008-11-13

Rapamycin Derivative or an Impdh Inhibitor For Treating Polycystic Kidney Disease

 #1192
20080279821
2008-11-13

ARYLPIPERIDINYL AND ARYLPYRROLIDINYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS

 #1193
20080275104
2008-11-06

METHODS OF TREATING JUVENILE TYPE 1 DIABETES MELLITUS

 #1194
20080274082
2008-11-06

OXIMYL HYDROXYAMIC ANALOGS AS HEPATITIS C VIRUS PROTEASE INHIBITOR

 #1195
20080269155
2008-10-30

REMEDY OR PREVENTIVE FOR KIDNEY DISEASE AND METHOD OF DIAGNOSING KIDNEY DISEASE

 #1196
20080267915
2008-10-30

Hcv Ns3-Ns4a Protease Inhibition

 #1197
20080261913
2008-10-23

Compounds and pharmaceutical compositions for the treatment of liver disorders

 #1198
20080260837
2008-10-23

Physically stable aqueous suspensions of active pharmaceuticals

 #1199
20080255087
2008-10-16

Compositions and methods for the treatment of cancer

 #1200
20080255067
2008-10-16

Cyanocobalamin low viscosity aqueous formulations for intranasal delivery